Prof. Neugebauer invited as expert to parliamentary health commission
Prof. Dr. Edmund Neugebauer, Director of the Institute for Research in Operative Medicine (IFOM), was invited as an expert to a hearing of the Federal Parliament's health commission.
He informed parliamentarians and representatives of the health sector on the safety of medical devices in a public hearing initiated by members of the Social Democratic and Bündnis 90/Die Grünen parliamentary groups. The topic had made headlines for months, triggered in particular by recent scandals concerning defective hip and breast implants. Prof. Neugebauer demanded that data on efficiency and safety of medical products of risk categories II b and III should be submitted prior to marketing authorization, in adaptation to the German Medicines Act (AMG). He suggested to establish an independent European institution for the marketing authorization of medical products.
Prof. Neugebauer was invited on the basis of his expertise as chairman of the national network of outcomes researchers, and also in his capacity as an expert in the national strategy process on medical products.
Here is the entire parliamentary hearing: die komplette Bundestagssitzung (Prof. Neugebauer starting from 1:17:00).